Recently, the Provincial Health Commission released the second batch of provincial key clinical specialty construction units in Shaanxi Province, which are listed in the list of Urology, hepatobiliary surgery and respiratory medicine of Xianyang central hospital.

In recent years, Xianyang central hospital has attached great importance to the construction of key disciplines, and has given active support in talent cultivation, diagnosis and treatment technology, scientific research and teaching, as well as the introduction of equipment. Among them, remarkable achievements have been made in urology, hepatobiliary and respiratory, especially in diagnosis and treatment technology.

Urology laparoscopic technology, percutaneous nephroscope technology, plasma, laser and other technologies are in the lead in China, with the minimally invasive surgery rate of more than 90%. Chief physician Xu Xiaofeng has been invited to major hospitals in China for many times or to conduct surgical demonstrations and academic lectures through remote means, and more than 30 batches of domestic peers have come to the hospital for observation and discussion. The Department is equipped with the most advanced medical equipment at home and abroad, including a full set of vaporized electric resection mirror, plasma, urodynamic, laparoscopic, visual cystoscopy, complete stone removal system, red laser, holmium laser, nephroscope, ureteroscope, green laser, Shuotong mirror, flexible ureteroscope, complete pneumatic ballistic lithotripsy system, stone analysis system, etc., with a total value of more than 30 million yuan. In the treatment of benign prostatic hyperplasia, the Department has carried out plasma resection of the prostate, 980nm red laser enucleation of the prostate and green laser vaporization of the prostate. A series of highly difficult operations have achieved routine and standardized treatment. In terms of urinary calculi, the Department has carried out advanced technologies such as percutaneous nephrolithotomy (including pneumatic ballistic lithotripsy, EMS ultrasonic lithotripsy, holmium laser lithotripsy), Shuotong holmium laser lithotripsy (the first in Northwest China) and flexible ureteroscopy. The treatment is individualized and accurate, which can meet the needs of different patients. In the aspect of urinary system tumor, laparoscopic resection of kidney, adrenal gland, retroperitoneal, bladder and prostate tumor was carried out. In terms of female urinary system diseases, the Department carried out urethra suspension (TVT, TVT-0), interstitial cystitis, bladder water expansion and other related operations.

Hepatobiliary surgery is a provincial characteristic specialty. The treatment of hepatobiliary and pancreatic tumor diseases is in a leading position in the province. At present, the discipline has two wards. The Department is one belt, one road, the first ERCP training base in Xianyang province (the annual ERCP operation volume is more than 700, and the total number of ERCP is over 7000). The earliest liver, gallbladder, pancreas and spleen specialist in Xianyang, the innovation team of minimally invasive and cellular immunotherapy technology for complex hepatobiliary and pancreatic diseases, is located in the city. Laparoscopic pancreaticoduodenectomy, laparoscopic radical resection of cholangiocarcinoma, laparoscopic splenectomy and devascularization, laparoscopic distal pancreatectomy, laparoscopic radical resection of colorectal cancer, laparoscopic choledochal cyst resection, choledochojejunostomy, laparoscopic gastrointestinal bypass, laparoscopic lobectomy and other highly difficult minimally invasive operations, as well as liver cancer, hilar cholangiocarcinoma, gallbladder cancer, extrahepatic and extrahepatic The operation of bile duct stones, pancreatic cancer, gastrointestinal benign and malignant tumors, endocrine surgical diseases standardized treatment and other high difficulty surgery, realized the procedure, standardization, refinement and minimally invasive surgical treatment of liver and gallbladder diseases.

The total investment of respiratory medicine in recent 10 years is nearly 10 million yuan, only in recent three years, the total investment is about 5 million yuan. It is equipped with a complete set of respiratory endoscopy, ventilator, respiratory auxiliary treatment instrument, and has four complete diagnosis and treatment centers, with the characteristics of respiratory interventional diagnosis and treatment technology, respiratory critical disease diagnosis and treatment technology, respiratory chronic disease management and lung rehabilitation. At present, the Department of respiratory medicine has developed TBNA / TBLB / ttna diagnostic technology, argon knife, Nd-YAG laser ablation technology, frozen biopsy and cryotherapy technology, medical thoracoscopic intervention technology, multi-path particle implantation technology, pulmonary vascular interventional diagnosis and treatment technology, invasive and non-invasive ventilator sequential treatment, bedside endoscopic intervention technology, bedside ultrasound diagnosis and treatment technology, high flow ventilation treatment Treatment technology, bedside CRRT treatment technology. The Department is the national PCCM standardization construction standard unit, Shaanxi Provincial respiratory disease clinical medicine research sub center, provincial lung cancer standardized diagnosis and treatment municipal demonstration center, Xianyang respiratory disease diagnosis and treatment quality control center, municipal respiratory discipline key specialty, municipal respiratory and critical care medical technology innovation team, and is also the lung cancer MDT team of Peking Union Medical College Hospital, Xianyang diagnosis and treatment center, China Lung cancer prevention and treatment alliance Xianyang central hospital pulmonary nodule diagnosis and treatment center, lung cancer integrated diagnosis and treatment center (ILCC), national respiratory disease clinical medicine research center three collaborative innovation units.

The construction of provincial key clinical specialties is of far-reaching significance. In the future, Xianyang central hospital will actively promote the construction of provincial key clinical specialties, which will play a positive role in strengthening the level of clinical technology and service, playing the role of demonstration and radiation of key specialties, and promoting the overall improvement of regional medical service level.